Representative Eshoo honored as BIO Legislator of the Year.
Share:
Press Release Summary:
BIO announced its selection of Congresswoman Anna Eshoo as Legislator of the Year for 2009-2010. According to BIO President and CEO Jim Greenwood, as a member of the Energy and Commerce Subcommittee on Health, Representative Eshoo has been a proponent of issues critical to nation's biotech industry such as the creation of a pathway for approval of biosimilars that protects patient safety and provides incentives for continued innovation.
Original Press Release:
Representative Eshoo Honored as BIO Legislator of the Year
WASHINGTON, D.C. - The Biotechnology Industry Organization (BIO) announced today its selection of Congresswoman Anna Eshoo (D-CA) as Legislator of the Year for 2009-2010. Representative Eshoo received the award as part of the BIO Legislative Day Fly-In earlier this week.
"Representative Eshoo is a long-time champion of the biotechnology industry. As a member of the Energy and Commerce Subcommittee on Health, she been a proponent of issues critical to our nation's biotech industry such as the creation of a pathway for the approval of biosimilars that protects patient safety and provides incentives for continued innovation," said BIO President and CEO Jim Greenwood.
More than 200 biotechnology industry representatives from 32 states will participate in hundreds of meetings with Members of the House and Senate during the BIO Legislative Day Fly-In. Participants will discuss issues critical to the biotechnology industry including patent reform, NIH/ FDA funding, drug importation risks, and expanded eligibility for Small Business Innovation Research grants.
About BIO
BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world's largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.
